TipRanks
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Hong Kong Market
6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:6826 full AI Analyst Report?

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Ratios

0 Followers

Shanghai Haohai Biological Technology Co., Ltd. Class H Ratios

HK:6826's free cash flow for Q2 2026 was ¥0.59. For the 2026 fiscal year, HK:6826's free cash flow was decreased by ¥ and operating cash flow was ¥0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.49 3.79 4.22 5.24 6.91
Quick Ratio
 2.95 3.21 3.66 4.50 5.96
Cash Ratio
 2.42 2.68 3.04 3.83 4.97
Solvency Ratio
 0.34 0.40 0.50 0.56 0.39
Operating Cash Flow Ratio
 0.52 0.69 0.75 0.89 0.45
Short-Term Operating Cash Flow Coverage
 1.17 2.00 2.26 3.23 17.77
Net Current Asset Value
¥ 2.26B¥ 2.35B¥ 2.45B¥ 2.66B¥ 2.54B
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.06 0.06 0.06 0.02
Debt-to-Equity Ratio
 0.08 0.07 0.08 0.07 0.02
Debt-to-Capital Ratio
 0.08 0.07 0.07 0.07 0.02
Long-Term Debt-to-Capital Ratio
 0.00 <0.01 0.02 0.03 <0.01
Financial Leverage Ratio
 1.24 1.24 1.28 1.26 1.25
Debt Service Coverage Ratio
 0.73 1.25 1.50 3.03 19.50
Interest Coverage Ratio
 3.77 12.05 19.26 60.09 20.49
Debt to Market Cap
 0.07 0.07 0.07 0.08 0.01
Interest Debt Per Share
 2.05 1.79 2.00 2.43 0.73
Net Debt to EBITDA
 -6.22 -4.59 -3.97 -3.27 -5.41
Profitability Margins
Gross Profit Margin
98.65%69.06%69.74%70.34%68.79%
EBIT Margin
3.59%9.78%13.88%19.57%11.57%
EBITDA Margin
12.85%18.23%20.49%27.08%21.28%
Operating Profit Margin
2.90%9.06%12.98%16.64%7.41%
Pretax Profit Margin
5.81%9.78%17.40%19.29%11.21%
Net Profit Margin
6.50%10.00%15.69%15.79%8.58%
Continuous Operations Profit Margin
6.81%8.30%14.04%15.65%9.05%
Net Income Per EBT
111.78%102.20%90.20%81.87%76.56%
EBT Per EBIT
200.40%107.95%133.98%115.94%151.29%
Return on Assets (ROA)
2.33%3.64%5.90%5.86%2.62%
Return on Equity (ROE)
2.80%4.51%7.54%7.36%3.27%
Return on Capital Employed (ROCE)
1.22%3.82%5.56%6.86%2.44%
Return on Invested Capital (ROIC)
1.13%3.15%4.28%5.38%1.96%
Return on Tangible Assets
2.63%4.04%7.02%6.98%3.17%
Earnings Yield
2.21%4.80%7.21%9.90%4.47%
Efficiency Ratios
Receivables Turnover
 6.70 8.88 7.26 7.82 5.42
Payables Turnover
 25.65 11.10 13.06 14.18 12.04
Inventory Turnover
 2.21 1.45 1.65 1.49 1.35
Fixed Asset Turnover
 1.41 1.27 1.51 1.70 1.49
Asset Turnover
 0.36 0.36 0.38 0.37 0.31
Working Capital Turnover Ratio
 0.96 0.92 0.92 0.87 0.67
Cash Conversion Cycle
 205.10 260.53 243.21 266.73 306.83
Days of Sales Outstanding
 54.47 41.12 50.31 46.69 67.38
Days of Inventory Outstanding
 164.86 252.29 220.86 245.78 269.78
Days of Payables Outstanding
 14.23 32.88 27.95 25.74 30.32
Operating Cycle
 219.33 293.41 271.16 292.48 337.15
Cash Flow Ratios
Operating Cash Flow Per Share
 2.21 2.70 2.78 3.72 1.33
Free Cash Flow Per Share
 1.16 1.92 1.21 2.15 -0.49
CapEx Per Share
 1.05 0.78 1.57 1.56 1.83
Free Cash Flow to Operating Cash Flow
 0.52 0.71 0.44 0.58 -0.37
Dividend Paid and CapEx Coverage Ratio
 0.85 1.55 1.04 1.86 0.53
Capital Expenditure Coverage Ratio
 2.10 3.45 1.77 2.37 0.73
Operating Cash Flow Coverage Ratio
 1.12 1.58 1.45 1.56 1.96
Operating Cash Flow to Sales Ratio
 0.21 0.26 0.24 0.24 0.11
Free Cash Flow Yield
4.45%8.76%4.85%8.73%-2.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 45.93 20.29 13.91 10.11 22.35
Price-to-Sales (P/S) Ratio
 2.49 2.08 2.18 1.60 1.92
Price-to-Book (P/B) Ratio
 1.30 0.94 1.05 0.74 0.73
Price-to-Free Cash Flow (P/FCF) Ratio
 22.46 11.41 20.61 11.45 -46.98
Price-to-Operating Cash Flow Ratio
 13.92 8.10 9.00 6.63 17.44
Price-to-Earnings Growth (PEG) Ratio
 -0.57 -0.51 -0.53 0.08 -0.47
Enterprise Value Multiple
 13.18 6.83 6.65 2.63 3.60
Enterprise Value
 3.98B 3.04B 3.65B 1.87B 1.61B
EV to EBITDA
 13.18 6.83 6.65 2.63 3.60
EV to Sales
 1.69 1.24 1.36 0.71 0.77
EV to Free Cash Flow
 15.26 6.82 12.91 5.10 -18.75
EV to Operating Cash Flow
 8.00 4.84 5.63 2.95 6.96
Tangible Book Value Per Share
 20.94 21.22 20.54 28.55 27.13
Shareholders’ Equity Per Share
 23.60 23.34 23.92 33.09 31.78
Tax and Other Ratios
Effective Tax Rate
 -0.17 0.13 0.19 0.19 0.19
Revenue Per Share
 10.45 10.53 11.50 15.43 12.12
Net Income Per Share
 0.68 1.05 1.80 2.44 1.04
Tax Burden
 1.12 1.02 0.90 0.82 0.77
Interest Burden
 1.62 1.00 1.25 0.99 0.97
Research & Development to Revenue
 0.12 0.09 0.10 0.08 0.09
SG&A to Revenue
 0.77 0.51 0.46 0.16 0.19
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 0.01
Income Quality
 3.26 2.57 1.39 1.25 0.98
Currency in CNY